BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 14722391)

  • 1. Hypercalcemia in patients with disseminated coccidioidomycosis.
    Caldwell JW; Arsura EL; Kilgore WB; Reddy CM; Johnson RH
    Am J Med Sci; 2004 Jan; 327(1):15-8. PubMed ID: 14722391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disseminated coccidioidomycosis associated with hypercalcemia.
    Westphal SA
    Mayo Clin Proc; 1998 Sep; 73(9):893-4. PubMed ID: 9737228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercalcemia in coccidioidomycosis.
    Parker MS; Dokoh S; Woolfenden JM; Buchsbaum HW
    Am J Med; 1984 Feb; 76(2):341-4. PubMed ID: 6607675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total ionized serum calcium and parathyroid hormone levels in patients with disseminated coccidioidomycosis.
    Walter RM; Lawrence RM
    Am J Med Sci; 1981; 281(2):97-9. PubMed ID: 7234897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercalcemia in disseminated coccidioidomycosis: expression of parathyroid hormone-related peptide is characteristic of granulomatous inflammation.
    Fierer J; Burton DW; Haghighi P; Deftos LJ
    Clin Infect Dis; 2012 Oct; 55(7):e61-6. PubMed ID: 22670039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous pamidronate for hypercalcemia of primary hyperparathyroidism.
    Tal A; Graves L
    South Med J; 1996 Jun; 89(6):637-40. PubMed ID: 8638211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercalcemia associated with infection by Cryptococcus neoformans and Coccidioides immitis.
    Ali MY; Gopal KV; Llerena LA; Taylor HC
    Am J Med Sci; 1999 Dec; 318(6):419-23. PubMed ID: 10616168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy.
    Schilling T; Pecherstorfer M; Blind E; Leidig G; Ziegler R; Raue F
    J Clin Endocrinol Metab; 1993 Mar; 76(3):801-3. PubMed ID: 8445039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating PTH and PTHrP levels before and after treatment of tumor induced hypercalcemia with Pamidronate Disodium (APD).
    Grill V; Murray RM; Ho PW; Santamaria JD; Pitt P; Potts C; Jerums G; Martin TJ
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1468-70. PubMed ID: 1592895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pamidronate treatment in patients with tumor-associated hypercalcemia: pharmacological effects and pharmacokinetics.
    Oiso Y; Tomita A; Hasegawa H; Ariyoshi Y; Niinomi M; Yamamoto M; Takano T; Sakiyama N
    Endocr J; 1994 Dec; 41(6):655-61. PubMed ID: 7704089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of plasma PTH-rp in patients with hypercalcemia of malignancy treated with bisphosphonate.
    Wimalawansa SJ
    Cancer; 1994 Apr; 73(8):2223-30. PubMed ID: 8156530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercalcemia secondary to leprosy.
    Couri CE; Foss NT; Dos Santos CS; de Paula FJ
    Am J Med Sci; 2004 Dec; 328(6):357-9. PubMed ID: 15599334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia.
    Gucalp R; Ritch P; Wiernik PH; Sarma PR; Keller A; Richman SP; Tauer K; Neidhart J; Mallette LE; Siegel R
    J Clin Oncol; 1992 Jan; 10(1):134-42. PubMed ID: 1727915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercalcemia due to sun exposure in a patient with multiple myeloma and elevated parathyroid hormone-related protein.
    Papapetrou PD; Bergi-Stamatelou M; Karga H; Thanou S
    Eur J Endocrinol; 2003 Mar; 148(3):351-5. PubMed ID: 12611617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercalcemia as a result of sarcoidosis with normal serum concentrations of vitamin D.
    Falk S; Kratzsch J; Paschke R; Koch CA
    Med Sci Monit; 2007 Nov; 13(11):CS133-136. PubMed ID: 17968303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of chemotherapy on hypercalcemia in breast and lung cancer patients.
    Hassan BA; Yusoff ZB; Hassali MA; Othman SB; Weiderpass E
    Asian Pac J Cancer Prev; 2012; 13(9):4373-8. PubMed ID: 23167346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism.
    Jansson S; Tisell LE; Lindstedt G; Lundberg PA
    Surgery; 1991 Sep; 110(3):480-6. PubMed ID: 1845370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypercalcemia, symptoms, differential diagnostics and treatment, or importance of calcium investigation].
    Adam Z; Starý K; Kubinyi J; Zajíčková K; Řehák Z; Koukalová R; Tomíška M; Doubková M; Prášek J; Pourová E; Čermáková Z; Pour L; Krejčí M; Sandecká V; Ševčíková E; Ševčíková S; Král Z; Čermák A
    Vnitr Lek; 2016; 62(5):370-83. PubMed ID: 27319230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercalcemia in disseminated coccidioidomycosis.
    Lee JC; Catanzaro A; Parthemore JG; Roach B; Deftos LJ
    N Engl J Med; 1977 Aug; 297(8):431-3. PubMed ID: 882114
    [No Abstract]   [Full Text] [Related]  

  • 20. Factors predicting the acute effect of pamidronate on serum calcium in hypercalcemia of malignancy.
    Gallacher SJ; Fraser WD; Logue FC; Dryburgh FJ; Cowan RA; Boyle IT; Ralston SH
    Calcif Tissue Int; 1992 Dec; 51(6):419-23. PubMed ID: 1333351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.